Maravai LifeSciences Holdings Inc Ordinary Shares - Class A (MRVI)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$3.50
Buy
$4.00
$-0.11 (-2.96%)
Prices updated at 12 Dec 2025, 21:10 EST
| Prices minimum 15 mins delay
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Biotechnology
Chairman
Mr. Robert Andrew Eckert
CEO
Mr. Bernd Brust
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
550
Head office
10770 Wateridge Circle
San Diego
United States
92121
Key personnel
Owner name | Salary |
|---|---|
Mr. Bernd Brust Director and Chief Executive Officer | - |
Mr. Rajesh J. Asarpota Chief Financial Officer | - |
Mr. Gregory T. Lucier Independent Director | 0.06m |
Dr. John A. DeFord, PhD Independent Director | 0.09m |
Ms. Christine Dolan Executive Vice President and General Manager, Cygnus Technologies | - |
Mr. Sean L. Cunningham Director | 0.07m |
Mr. Constantine S. Mihas Director | 0.07m |
Mr. Kurt Oreshack General Counsel and Secretary | - |
Ms. Susannah Gray, M.B.A. Independent Director | 0.10m |
Mr. Luke Marker Director | 0.06m |
Mr. Robert Andrew Eckert Chairman of the Board | - |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| GTCR Investment XI LLC | 130,834,085 |
| GTCR LLC | 20,150,005 |
| 12 West Capital Management LP | 12,521,335 |
| Vanguard Group Inc | 9,380,547 |
| BlackRock Inc | 9,103,866 |
Director dealings
Date | Action |
|---|---|
| 09 Dec 2024 | - |
| 09 Dec 2024 | - |
| 15 Nov 2024 | - |
| 12 Nov 2024 | - |
| 11 Nov 2024 | - |
| 31 Oct 2024 | - |
| 31 Oct 2024 | - |
| 31 Oct 2024 | - |
| 31 Oct 2024 | - |
| 15 Oct 2024 | - |
| 15 Jul 2024 | - |
| 23 May 2024 | - |
| 23 May 2024 | - |
| 23 May 2024 | - |
| 23 May 2024 | - |
| 23 May 2024 | - |
| 23 May 2024 | - |
| 23 May 2024 | - |
| 23 May 2024 | - |
| 23 May 2024 | - |
Please note that past performance is not a reliable indicator of future returns.